Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Communicable Diseases Surveillance: CDI volume 26 issue 4 (2002)
View through CrossRef
Communicable diseases surveillance highlights for 3rd quarter, 2002 (gastrointestinal disease, quarantinable disease, sexually transmitted infections, vaccine preventable diseases, other bacterial diseases, LabVISE), and surveillance outcomes from several reporting series as follows:National Notifiable Diseases Surveillance System tables, 1 July to 30 September 2001;Laboratory Serology and Virology Reporting Scheme tables, 1 July to 30 September 2002;Australian Sentinel Practices Research Network, reporting period 1 July to 30 September 2002 (cumulation of year to date);Gonococcal surveillance, reporting period 1 April to 30 June 2002;Australian Paediatric Surveillance Unit (APSU), reporting period 1 January to 30 December 2001;HIV and AIDS surveillance, reporting period 1 April to 30 June 2002, assessed as at 30 September 2002;Australian childhood immunisation coverage, 1 April to 30 June 2002 cohort, assessed as at 30 September 2002;National Enteric Pathogens Surveillance System, reporting period 1 July to 30 September 2002.
Title: Communicable Diseases Surveillance: CDI volume 26 issue 4 (2002)
Description:
Communicable diseases surveillance highlights for 3rd quarter, 2002 (gastrointestinal disease, quarantinable disease, sexually transmitted infections, vaccine preventable diseases, other bacterial diseases, LabVISE), and surveillance outcomes from several reporting series as follows:National Notifiable Diseases Surveillance System tables, 1 July to 30 September 2001;Laboratory Serology and Virology Reporting Scheme tables, 1 July to 30 September 2002;Australian Sentinel Practices Research Network, reporting period 1 July to 30 September 2002 (cumulation of year to date);Gonococcal surveillance, reporting period 1 April to 30 June 2002;Australian Paediatric Surveillance Unit (APSU), reporting period 1 January to 30 December 2001;HIV and AIDS surveillance, reporting period 1 April to 30 June 2002, assessed as at 30 September 2002;Australian childhood immunisation coverage, 1 April to 30 June 2002 cohort, assessed as at 30 September 2002;National Enteric Pathogens Surveillance System, reporting period 1 July to 30 September 2002.
Related Results
A Retrospective Analysis of Risk Factors for Severe Clostridium Difficile Infection In Acute Leukemia and Aggressive Lymphoma.
A Retrospective Analysis of Risk Factors for Severe Clostridium Difficile Infection In Acute Leukemia and Aggressive Lymphoma.
Abstract
Abstract 3797
Introduction and Goals.
Clostridium difficile infection (CDI) is increasing in frequency a...
Impact of exposure to potentially contaminated hospital beds on risk of hospital-onset C. difficile infection
Impact of exposure to potentially contaminated hospital beds on risk of hospital-onset C. difficile infection
Background: Environmental contamination increases risk for Clostridioides difficile infection (CDI) given that spores can remain on a hospital bed, floor, sink, and light switch de...
P035 Clostridium difficile infection in ulcerative colitis: Data from the tofacitinib clinical program and an insurance claims database
P035 Clostridium difficile infection in ulcerative colitis: Data from the tofacitinib clinical program and an insurance claims database
BACKGROUND:
Patients with inflammatory bowel disease (IBD), particularly ulcerative colitis (UC), have a higher risk of Clostridium difficile infection (CDI) than the g...
2824 Inpatient Fecal Microbiota Transplantation for the Treatment of Refractory Severe-Complicated Clostridioides difficile Infection
2824 Inpatient Fecal Microbiota Transplantation for the Treatment of Refractory Severe-Complicated Clostridioides difficile Infection
INTRODUCTION:
Currently, surgery is the primary treatment option for refractory, severe-complicated Clostridioides difficile infection (CDI) in the inpatient setting. T...
794. Healthcare-Associated Urinary Tract Infection (HA-UTI): A Risk Factor for Clostridioides difficile Infection (CDI)? Results of a Real-World Data Analysis
794. Healthcare-Associated Urinary Tract Infection (HA-UTI): A Risk Factor for Clostridioides difficile Infection (CDI)? Results of a Real-World Data Analysis
Abstract
Background
It is estimated that 223,900 cases of CDI occur annually in hospitalized patients resulting in 12,800 deaths...
P-1019. Comparative Analysis of C. difficile Isolates from Recurrent and Non-Recurrent Infections: Outcomes, Antimicrobial Susceptibility, and Biofilm Formation
P-1019. Comparative Analysis of C. difficile Isolates from Recurrent and Non-Recurrent Infections: Outcomes, Antimicrobial Susceptibility, and Biofilm Formation
Abstract
Background
Clostridioides difficile infection (CDI) is a serious diarrheal illness caused by microbiota disrupti...
2432. Durability Against Antibiotics After Response to Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
2432. Durability Against Antibiotics After Response to Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
Abstract
Background
Fecal microbiota transplantation (FMT) cures ~90% of patients with recurrent Clostridioides difficile infect...
Analisis Penyebab Kerusakan CDI Pada Mesin Motor Beat 110CC
Analisis Penyebab Kerusakan CDI Pada Mesin Motor Beat 110CC
Besar atau kecilnya performa dalam suatu mesin salah satunya dapat dipengaruhi oleh sistem pengapiannya. CDI (Capacitor Discharge Ignition) adalah Sebuah komponen dalam sistem peng...